12 ileri kurs1 - Kan Merkezleri ve Transfüzyon Derneği
12 ileri kurs1 - Kan Merkezleri ve Transfüzyon Derneği
12 ileri kurs1 - Kan Merkezleri ve Transfüzyon Derneği
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Ulusal <strong>Kan</strong> <strong>Merkezleri</strong> <strong>ve</strong> <strong>Transfüzyon</strong> T›bb› Kursu XII - ‹leri Kurs<br />
ya da üstün duyarl›l›kta <strong>ve</strong> kan›n mikrobiyolojik taramas› için onaylanm›fl ikinci bir kiti kan merkezinde rutin olarak<br />
uygulayabilir ya da iflaretlenmifl kan ba¤›flç›lar›n›n taramas›nda kullanabilir. Test sonuçlar›na göre kan ba¤›flç›s› tekrar<br />
kabul edilse de, kay›tlar›, viral göstergenin önceki hatal› reakvitesini belirtecek flekilde muhafaza edilmelidir.<br />
Nötralizasyon ile do¤rulanamayan HBs Ag ya da tutars›z HBsAg, HBV DNA <strong>ve</strong> anti HBc sonuçlar› bulunan kan ba-<br />
¤›flç›lar›n›n tekrar kan örne¤i alt›nc› ayda al›nmal›d›r.<br />
<strong>Kan</strong> ba¤›flç›s›n›n test sonuçlar› HIV, HCV ya da HBV ile enfeksiyona iflaret ederse, kan merkezinde yap›lmas› gereken<br />
ifllemlere “lookback” denir. Bu ifllemler ayn› zamanda kan ba¤›flç›s›n›n pencere döneminde tarama testleri negatifken<br />
yapm›fl oldu¤u önceki ba¤›fllar› kapsar. Bunlar; stokta bulunan, halen kullan›lmam›fl, gün içindeki ba¤›fllar›n karantinaya<br />
al›nmas›, kan da¤›t›lan merkezlerin ba¤›flç›ya ait, zaman› içindeki bileflenler konusunda bilgilendirilmesi, kan<br />
ba¤›flç›s›n›n <strong>ileri</strong> testlerinin yap›lmas›, önceki ba¤›fllar›n etiketlerinin de¤ifltirilmesi <strong>ve</strong> imha edilmesi ile ba¤›flç›dan daha<br />
önce kan alm›fl olan al›c›lar›n bilgilendirilmesi ifllemleridir.<br />
KAYNAKLAR<br />
1. Laperche S. Antigen antibody combination assays for blood donor screening: weighing the advantages and<br />
costs. Editorial. Transfusion 2008; 48: 576-579.<br />
2. Schmidt M, Nübling CM, Schblauer H, et al. Anti HBc screening of blood donors: a comparison of nine anti<br />
HBc tests. Vox Sanguinis 206; 91: 237-243.<br />
3. Centers for Disease Control and Pre<strong>ve</strong>ntion: Department of Health and Human Services. Guideline for laboratory<br />
testing and result reporting of antibody to hepatitis C virus. Morbidity and Mortality Weekly Report 2003;<br />
52 (No.RR-3): 1-13.<br />
4. Marshall DA, Kleinman SH, Wong JB, et al. Cost effecti<strong>ve</strong>ness of nucleic acid test screening of volunteer blood<br />
donations for hepatitis B, hepatitis C and human immunodeficiency virus in the United States. Vox Sanguinis<br />
2004; 86: 28-40.<br />
5. Centers for Disease Control and Pre<strong>ve</strong>ntion: Department of Health and Human Services. Guidance for industry.<br />
Eligibility determination for donors of human cells, tissues and cellular and tissue based products. August 2007:<br />
p21-26.<br />
6. Kleinman S, Wang B, Wu Y, et al. The donor notification process from the donor’s perspecti<strong>ve</strong>. Transfusion<br />
2004; 44: 658-666.<br />
7. Blood products advisory committee. Reentry for donors deferred because of HIV or HCV NAT or serological<br />
test results. 69th meeting-June 14-15 2001.<br />
8. Soldan K, Barbara JAJ, Ramsay ME, Hall AJ. Estimation of the risk of hepatitis B virus, hepatitis C virus and human<br />
immunodeficiency virus infectious donations entering the blood supply in England, 1993-2001. Vox Sanguinis<br />
2003; 84: 274-286.<br />
9. Centers for Disease Control and Pre<strong>ve</strong>ntion: Department of Health and Human Services. Guidance for industry.<br />
Nucleic acid testing for human immunodeficiency virus type 1 and hepatitis C virus: Testing, product disposition,<br />
and donor deferrel and reentry. July 2005:p1-24.<br />
10. O’Brien SF, Yi QL, Fan W, et al. Impact of a policy to permit the return of donors repeat-reacti<strong>ve</strong> to the Abbott<br />
Prism antibody to hepatitis B core antigen assay. Transfusion 2009; 49: 271-277.<br />
11. Christensen PB, Titlestad IL, Homburg KM, et al. Hepatitis B core antibodies in Danish blood donors: a surrogate<br />
marker of risk behaviour. Vox Sanguinis 2001; 81: 222-227.<br />
<strong>12</strong>. Bhatti FA, Ullah Z, Salamat N, et al. Anti hepatitis B core antigen testing, viral markers and occult hepatitis B<br />
infection in Pakistani blood donors: implications for transfusion practice. Transfusion 2007; 47: 74-79.<br />
13. Niederhauser C, Taleghani BM, Graziani M. Blood donor screening: how to decrease the risk of transfusion<br />
transmitted-hepatitis B virus. Swiss Med Wkly 2008; 138 (9-10): 134-141.<br />
14. Lucey C. Brief report on the United States Food and Drug Administration Blood Products Advisory Committee<br />
recommendations for management of donors and units testing positi<strong>ve</strong> for hepatitis B virus DNA. Vox Sangui-<br />
- 76 -
Change language